NCT01737944View on ClinicalTrials.gov

Exposure Study Comparing 3 Routes of Methotrexate (MTX) Administration

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

May 31, 2011

Study Completion Date

June 30, 2011

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Methotrexate (MTX)

Vibex MTX Device

Trial Locations (1)

16635

Altoona Center for Clinical Research, Duncansville

Sponsors
All Listed Sponsors
lead

Antares Pharma Inc.

INDUSTRY

NCT01737944 - Exposure Study Comparing 3 Routes of Methotrexate (MTX) Administration | Biotech Hunter | Biotech Hunter